Spiber Inc.

Headquarters: Japan

Filing date: 2026-11-10

Estimated valuation: $2.5B

Executive Summary

Spiber is a Japanese biotechnology firm that has pioneered the commercial production of Brewed Protein, a structural protein material produced through microbial fermentation. By utilizing plant-derived sugars rather than petroleum, Spiber’s materials offer a sustainable alternative to animal-based and synthetic textiles. The company has partnered with brands like The North Face and Moncler to release high-end apparel products. Revenue is currently modest as the company transitions from pilot to mass-production phase at its Thailand plant. Risks include the high capital expenditure required for global scaling and the technical difficulty of protein synthesis at scale. The IPO represents a unique sustainability-focused investment in the materials science sector, targeting the luxury and performance apparel markets.

Risk Analysis

Detailed risk factors, AI-graded risk score, financials, and analyst commentary for Spiber Inc. are available to Pro subscribers.

Unlock the full report or browse 500+ pre-IPO prospects.